scispace - formally typeset
T

Takao Ohtsuka

Researcher at Kyushu University

Publications -  285
Citations -  7415

Takao Ohtsuka is an academic researcher from Kyushu University. The author has contributed to research in topics: Pancreatic cancer & Cancer. The author has an hindex of 39, co-authored 245 publications receiving 5896 citations. Previous affiliations of Takao Ohtsuka include Saga University & University of Iowa Hospitals and Clinics.

Papers
More filters
Journal ArticleDOI

Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas.

TL;DR: The working group has revised the guidelines regarding prediction of invasive carcinoma and high-grade dysplasia, surveillance, and postoperative follow-up of IPMN and includes updated information and recommendations based on the current understanding.
Journal ArticleDOI

ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway.

TL;DR: Evidence is presented that ASC can function as an adaptor molecule for Bax and regulate a p53–Bax mitochondrial pathway of apoptosis and induction of ASC after exposure to genotoxic stress is dependent on p53.
Journal ArticleDOI

Intraductal Papillary-Mucinous Tumor of the Pancreas Concomitant with Ductal Carcinoma of the Pancreas

TL;DR: Clinicians should pay attention to the possible presence of DC of the pancreas in male patients with intraductal papillary-mucinous adenoma of the Pancreas of branch type in their 6th to 8th decades.
Journal ArticleDOI

Autophagy is Required for Activation of Pancreatic Stellate Cells, Associated With Pancreatic Cancer Progression and Promotes Growth of Pancreatic Tumors in Mice.

TL;DR: Autophagic PSCs produce ECM molecules and interleukin 6 and are associated with shorter survival times and disease recurrence in patients with pancreatic cancer, and inhibitors of PSC autophagy might reduce pancreatic tumor invasiveness by altering the tumor stroma.
Journal ArticleDOI

Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy

TL;DR: Quantitative analyses of hENT1, dCK, RRM1, and RRM2 mRNA levels using FFPE tissue samples and microdissected neoplastic cells from EUS-FNA cytologic specimens may be useful in predicting the gemcitabine sensitivity of patients with PDAC.